The previous research findings demonstrated that N-terminal-pro brain natriuretic peptide levels, lower prothrombin activity (<70%), and albumin levels (<40 g/L) indicate a high-risk status for poor clinical outcomes in patients with CHD [51]. This evidence concerns the gene ALB and coronary artery disorder.